Carlos Campoy, Chief Financial Officer at CytomX Therapeutics, Inc. (CTMX), sold 3,949 shares at $1.42 ($6K) on 2022-07-20, disclosed to the SEC on 2022-07-21.
Open-market sale of $6k CTMX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.